Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

B of A Securities Downgrades Ardent Health to Underperform, Lowers Price Target to $14.6

Author: Benzinga Newsdesk | July 16, 2025 06:40am
B of A Securities analyst Kevin Fischbeck downgrades Ardent Health (NYSE:ARDT) from Neutral to Underperform and lowers the price target from $15.5 to $14.6.

Posted In: ARDT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist